Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, studied for its powerful weight reduction and metabolic improvement potential. Manufactured under stringent quality control standards to ensure...
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, studied for its powerful weight reduction and metabolic improvement potential.
Manufactured under stringent quality control standards to ensure consistency and integrity in research applications.
Notice: This product is intended strictly for research purposes. It is not for human consumption or use in diagnostic, therapeutic, or clinical procedures.
